ResearchSafe

Switching from KLOW to GLOW after 8 weeks, worth dropping KPV?

Posted by nina489 in Protocols & Stacks - 1 points, 0 comments.

I am basically finishing up an 8-week KLOW run (the full four-compound version with KPV included) and I am thinking about transitioning to GLOW for another 6-8 weeks as a sort of maintenance phase. The idea would be to drop KPV since my inflammation feels more under control now, no?

My KLOW dosing was the standard one. GHK-Cu 200mcg and BPC-157 500mcg daily, KPV 500mcg daily, TB-500 2.5mg twice a week. For me the recovery effect was noticeable (could be partly placebo, I accept that) but the injection site irritation from GHK-Cu was annoying the whole time.

So my question is whether it makes sense to go straight into GLOW or if I should take a full break first. I have seen people say 4 weeks off between stacks but I am not sure if that applies when the overlapping compounds are the same ones, right?

Also, for GLOW the listed dose keeps GHK-Cu daily but drops TB-500 to 2-3x per week. That is basically what I was already doing. Would there be any point in running it at all if the only real change is removing KPV? Seems like a very small adjustment.

Any feedback on the transition timing or whether this is just redundant would be helpful.

Community discussion - research and educational context only. Not medical advice.